Checkpoint Blockade Therapy May Sensitize Aggressive and Indolent Non-Hodgkin Lymphoma to Subsequent Therapy

被引：2

作者：

Carreau, Nicole A. ^{[1
]}

Pail, Orrin ^{[1
]}

Armand, Philippe ^{[2
]}

Merryman, Reid W. ^{[3
]}

Advani, Ranjana H. ^{[4
]}

Spinner, Michael A. ^{[5
]}

Herrera, Alex F. ^{[6
]}

Chen, Robert W. ^{[6
]}

Tomassetti, Sarah ^{[7
]}

Ramchandren, Radhakrishnan ^{[8
]}

Hamid, Muhammad ^{[9
]}

Assouline, Sarit ^{[10
]}

Santiago, Raoul ^{[10
]}

Wagner-Johnston, Nina D. ^{[11
]}

Paul, Suman ^{[12
]}

Svoboda, Jakub ^{[13
]}

Bair, Steven M. ^{[14
]}

Barta, Stefan Klaus ^{[15
]}

Liu, Yang ^{[16
]}

Nathan, Sunita ^{[17
]}

Burkart, Madelyn ^{[18
]}

Karmali, Reem ^{[19
]}

Torka, Pallawi ^{[20
]}

David, Kevin A. ^{[21
]}

Wei, Catherine ^{[21
]}

Lansigan, Frederick ^{[22
]}

Emery, Lukas ^{[22
]}

Persky, Daniel ^{[23
]}

Smith, Sonali M. ^{[24
]}

Chavez, Julio C. ^{[25
]}

Xia, Yuhe ^{[26
]}

Troxel, Andrea B. ^{[26
]}

Diefenbach, Catherine ^{[27
]}

机构：

[1] NYU Langone Hlth, New York, NY USA

[2] Dana Farber Canc Inst, Boston, MA 02115 USA

[3] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[4] Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA

[5] Stanford Univ, Stanford, CA 94305 USA

[6] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA

[7] City Hope Natl Med Ctr, Duarte, CA USA

[8] Karmanos Canc Inst, Dept Oncol, Detroit, MI USA

[9] Karmanos Canc Inst, Detroit, MI USA

[10] McGill Univ, Montreal, PQ, Canada

[11] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[12] Johns Hopkins Univ, Baltimore, MD USA

[13] Hosp Univ Penn, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA

[14] Hosp Univ Penn, Abramson Canc Ctr, 3400 Spruce St, Philadelphia, PA 19104 USA

[15] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[16] Fox Chase Canc Ctr, Dept Hematol Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[17] Rush Univ, Med Ctr, Chicago, IL 60612 USA

[18] Northwestern Univ, Chicago, IL 60611 USA

[19] Northwestern Univ, Div Hematol, Chicago, IL 60611 USA

[20] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA

[21] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA

[22] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA

[23] Univ Arizona, Ctr Canc, Div Hematol Oncol, Tucson, AZ USA

[24] Univ Chicago Med, Chicago, IL USA

[25] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[26] NYU, Sch Med, New York, NY USA

[27] NYU, Sch Med, Inst Canc, New York, NY USA

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-117448

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[31] Checkpoint Inhibitors Hodgkin Lymphoma and Non-Hodgkin Lymphoma
Hu, Bei
Jacobs, Ryan
Ghosh, Nilanjan
[J]. CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2018, 13 (06) : 543 - 554
[32] Improving second-line therapy in aggressive non-Hodgkin's lymphoma
Gisselbrecht, C
Mounier, N
[J]. SEMINARS IN ONCOLOGY, 2004, 31 (01) : 12 - 16
[33] Antibody-targeted therapy: a paradigm of innovative treatment strategies in indolent and aggressive B-cell non-Hodgkin lymphoma
van de Loosdrecht, AA
Huijgens, PC
Ossenkoppele, GJ
[J]. CURRENT OPINION IN HEMATOLOGY, 2004, 11 (06) : 419 - 425
[34] Early therapy monitoring with FDG-PET in aggressive non-Hodgkin’s lymphoma and Hodgkin’s lymphoma
Tatsuo Torizuka
Fumitoshi Nakamura
Toshihiko Kanno
Masami Futatsubashi
Etsuji Yoshikawa
Hiroyuki Okada
Masahide Kobayashi
Yasuomi Ouchi
[J]. European Journal of Nuclear Medicine and Molecular Imaging, 2004, 31 : 22 - 28
[35] Early therapy monitoring with FDG-PET in aggressive non-Hodgkin's lymphoma and Hodgkin's lymphoma
Torizuka, T
Nakamura, F
Kanno, T
Futatsubashi, M
Yoshikawa, E
Okada, H
Kobayashi, M
Ouchi, Y
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (01) : 22 - 28
[36] Cladribine in indolent non-Hodgkin's lymphoma
Sigal, Darren S.
Saven, Alan
[J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (04) : 535 - 545
[37] Immunochernotherapy in indolent non-Hodgkin's lymphoma
Czuczman, MS
[J]. SEMINARS IN ONCOLOGY, 2002, 29 (02) : 11 - 17
[38] Immunotherapy in indolent Non-Hodgkin's Lymphoma
Amhaz, Ghid
Bazarbachi, Ali
El-Cheikh, Jean
[J]. LEUKEMIA RESEARCH REPORTS, 2022, 17
[39] Current approaches to therapy for indolent non-Hodgkin's lymphomas
Cheson, BC
[J]. 17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 1357 - 1362
[40] Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin's lymphoma
Hainsworth, JD
Litchy, S
Burris, HA
Scullin, DC
Corso, SW
Yardley, DA
Morrissey, L
Greco, FA
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (20) : 4261 - 4267

← 1 2 3 4 5 →